Core Laboratories N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Core Laboratories N.V. generated cash of $24,789,000, which is less than the previous year. Cash used in financing activities reached the amount of -$18,445,000 last year. Net change in cash is therefore -$308,000.
Cash Flow
| 2014 | 303.44M | -42.06M | -263.12M |
|---|---|---|---|
| 2015 | 219.1M | -39.65M | -180.30M |
| 2016 | 131.88M | -14.72M | -124.89M |
| 2017 | 124.27M | -20.55M | -104.07M |
| 2018 | 111.82M | -70.63M | -42.47M |
| 2019 | 89.52M | -5.67M | -85.87M |
| 2020 | 57.86M | 7.85M | -63.00M |
| 2021 | 36.57M | -10.22M | -22.45M |
| 2022 | 24.95M | -3.85M | -23.37M |
| 2023 | 24.78M | -6.65M | -18.44M |
CLB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.42M | 17.70M | 13.80M | 11.09M | 13.11M | 14.4M | 14.76M | 22.49M | 23.35M | 25.08M |
Operating activities | ||||||||||
Net income | 37.02M | 19.65M | 20.21M | -96.92M | 93.70M | 79.78M | 83.09M | 63.85M | 114.93M | 258.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 15.78M | 17.16M | 18.51M | 20.86M | 22.60M | 23.08M | 24.94M | 26.87M | 27.45M | 26.69M |
Stock-based compensation expense | 13.97M | 7.75M | 19.09M | 7.39M | 20.87M | 34.19M | 22.94M | 22.07M | 21.27M | 20.47M |
| Deferred income tax benefit | 13.97M | 7.75M | 19.09M | 7.39M | 20.87M | 34.19M | 22.94M | 22.07M | 21.27M | 20.47M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.61M | -10.07M | -13.52M | 46.42M | -3.19M | 2.26M | -18.56M | 31.58M | 49.26M | 3.48M |
Inventories | -12.97M | -14.86M | -4.54M | 1.47M | -3.89M | -10.40M | 446K | 6.21M | 3.04M | 2.89M |
Accounts payable | -12.87M | 15.37M | 6.56M | -12.83M | -3.75M | -1.75M | 8.72M | -1.03M | -13.35M | -3.02M |
Cash generated by operating activities | 24.78M | 24.95M | 36.57M | 57.86M | 89.52M | 111.82M | 124.27M | 131.88M | 219.1M | 303.44M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 13.53M | 0 | -1.88M | -1.27M | -2.10M | -2.51M | -2.94M | -4.31M |
Investments In Property Plant And Equipment | -10.57M | -10.21M | -13.53M | -11.88M | -22.26M | -21.74M | -18.77M | -11.70M | -24.25M | -37.44M |
Acquisitions Net | 0 | 240K | 873K | 1.50M | 2.98M | -47.31M | 0 | -1.24M | -13.77M | -1.2M |
Cash generated by investing activities | -6.65M | -3.85M | -10.22M | 7.85M | -5.67M | -70.63M | -20.55M | -14.72M | -39.65M | -42.06M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 59.13M | 56M | 0 | 178M | 0 | 197.20M | 0 | 217M |
Payments for dividends | -1.86M | -1.85M | -1.83M | -12.44M | -97.57M | -97.25M | -97.14M | -95.14M | -94.23M | -89.08M |
Repurchases of common stock | -2.20M | -3.90M | -8.25M | -2.79M | -3.30M | -7.45M | -16.90M | -7.16M | -159.70M | -264.36M |
Repayments of term debt | -9M | -15M | -71M | -102M | 15M | -114M | 10M | -316.24M | 75.34M | -128.16M |
Cash used in financing activities | -18.44M | -23.37M | -22.45M | -63.00M | -85.87M | -42.47M | -104.07M | -124.89M | -180.30M | -263.12M |
Net Change In Cash | -308K | -2.27M | 3.89M | 2.71M | -2.02M | -1.28M | -364K | -7.73M | -856K | -1.73M |
Cash at end of period | 15.12M | 15.42M | 17.70M | 13.80M | 11.09M | 13.11M | 14.4M | 14.76M | 22.49M | 23.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |